Voluntary batch recall for Taxotere Concentrate for solution for infusion 20 mg/ml and 80 mg/4ml (SIN14106P, SIN14107P)

Sanofi-Aventis Singapore Pte. Ltd. has issued a Dear Healthcare Professional Letter to inform healthcare professionals of a voluntary recall for selected batches of Taxotere Concentrate for solution for infusion 20 mg/ml (SIN14106P) and Taxotere Concentrate for solution for infusion 80 mg/4ml (SIN14107P). A failure in the filling process has led to a low number of potentially over-concentrated Taxotere Concentrate vials. As a precautionary measure, Sanofi has initiated the voluntary recall of these affected batches. As a consequence, a risk of shortage is anticipated. Healthcare providers should carefully monitor patients for signs of toxicity and treat appropriately. In case of a shortage, patients previously treated with Taxotere should preferably be switched to an alternative. Please refer to the letter for details.
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.moh.gov.sg/hpp/, and follow the procedures below to access the MOH Alert system.

Step 1: On the top navigation ribbon of webpage, select 'For Healthcare Professionals' followed by 'Health Professionals Portal' and click on the choice of profession. User will be redirected to the specific HPP webpage for the selected profession.

Step 2: Click on the Restricted Content icon on the left panel of webpage and login via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’ section

Step 4: Click on the Drug Alert tab to view the DHCPLs.